New Drug Research Study Findings Reported from Northwestern University (Therapeutic Targeting of Metabolic Vulnerabilities In Cancers With Mll3/4-compass Epigenetic Regulator Mutations).

Předmět:
Zdroj: Cancer Weekly; 9/12/2023, p681-681, 1p
Databáze: Complementary Index